Medicines Amendment Regulations (No 2) 2015

  • revoked
  • Medicines Amendment Regulations (No 2) 2015: revoked, on 25 October 2018, by regulation 5 of the Medicines Amendment Regulations 2018 (LI 2018/179).

Reprint as at 25 October 2018

Coat of Arms of New Zealand

Medicines Amendment Regulations (No 2) 2015

(LI 2015/180)

Medicines Amendment Regulations (No 2) 2015: revoked, on 25 October 2018, by regulation 5 of the Medicines Amendment Regulations 2018 (LI 2018/179).

Jerry Mateparae, Governor-General

Order in Council

At Wellington this 27th day of July 2015

Present:
His Excellency the Governor-General in Council

Note

Changes authorised by subpart 2 of Part 2 of the Legislation Act 2012 have been made in this official reprint.

Note 4 at the end of this reprint provides a list of the amendments incorporated.

These regulations are administered by the Ministry of Health.

Pursuant to section 105(1)(j) of the Medicines Act 1981, His Excellency the Governor-General makes the following regulations, acting—

(a)

on the advice and with the consent of the Executive Council; and

(b)

on the advice of the Minister of Health tendered after consultation with the organisations or bodies appearing to the Minister to be representative of persons likely to be substantially affected.

Regulations

1 Title

These regulations are the Medicines Amendment Regulations (No 2) 2015.

2 Commencement

These regulations come into force on 6 August 2015.

3 Principal regulations

These regulations amend the Medicines Regulations 1984 (the principal regulations).

4 Schedule 1 replaced

Replace Schedule 1 with the Schedule 1 set out in the Schedule of these regulations.

Schedule Schedule 1 replaced

r 4

Schedule 1 Prescription, restricted, and pharmacy-only medicines

r 3

Every reference to a medicine in this schedule applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are—

•

preparations and admixtures containing any proportion of any substance listed in this schedule:

•

salts and esters of any substance listed in this schedule:

•

preparations or extracts of biological materials listed in this schedule:

•

salts or oxides of elements listed in this schedule.

Unless specific reference is made otherwise, every reference to a medicine in this schedule applies,—

•

if the medicine is an injection or eye preparation, to any concentration of that medicine; and

•

if the medicine is not an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol, or element unless specifically stated otherwise.

Part 1 Prescription medicines

Amending or replacing this Part may affect designated prescriber regulations under section 105(1)(q) of the Act.

1

19-norandrostenedione

2

2,4-dinitrochlorobenzene

3

4-aminopyridine

4

4-chloromethandienone

5

4-chlorotestosterone

6

5-aminolevulinic acid

7

Abacavir

8

Abatacept

9

Abciximab

10

Abiraterone

11

Abrus precatorius; at all strengths

12

Acamprosate

13

Acarbose

14

Acebutolol

15

Acepromazine

16

Acetanilides

17

Acetarsol

18

Acetazolamide

19

Acetohexamide

20

Acetylcarbromal

21

Acetylcholine; except in medicines containing 1 milligram or less per litre or per kilogram

22

Acetylcysteine; for injection or inhalation

23

Acetyldigitoxin

24

Acetylmethyldimethyloximidophenylhydrazine

25

Acetylstrophanthidin

26

Aciclovir; except for external use for the treatment of herpes labialis

27

Acipimox

28

Acitretin

29

Aclidinium bromide

30

Acokanthera ouabaio

31

Acokanthera schimperi

32

Aconitum spp; except when specified elsewhere in this schedule

33

Acrivastine

34

Adalimumab

35

Adapalene

36

Adefovir

37

Adenosine; for injection

38

Adinazolam

39

Adiphenine

40

Adonis vernalis

41

Adrafinil

42

Adrenal extract; except for dermal use in medicines containing 0.02% or less of ketosteroids

43

Adrenaline; in medicines containing more than 1%

44

Adrenocortical hormones; except adrenal extract for dermal use containing 0.02% or less of ketosteroids

45

Afamelanotide

46

Afatinib

47

Aflibercept

48

Agalsidase

49

Agomelatine

50

Alatrofloxacin

51

Albendazole

52

Albumin; except human albumin

53

Alclofenac

54

Alclometasone; except when specified elsewhere in this schedule

55

Alcohol; for injection in medicines containing more than 20%

56

Alcuronium

57

Aldesleukin

58

Aldosterone; except in medicines containing 10 micrograms or less per litre or per kilogram

59

Alefacept

60

Alemtuzumab

61

Alendronic acid

62

Alfacalcidol

63

Alfentanil

64

Alfuzosin

65

Alglucerase

66

Alglucosidase

67

Aliskiren

68

Alkyl sulfonals

69

Allergens

70

Allopurinol

71

Allylisopropylacetylurea; at all strengths

72

Allyloestrenol

73

Alogliptin

74

Alosetron

75

Alpha1-proteinase inhibitor

76

Alphadolone

77

Alphaxalone

78

Alprazolam

79

Alprenolol

80

Alprostadil

81

Alseroxylon

82

Alteplase

83

Altretamine

84

Amantadine

85

Ambenonium

86

Ambrisentan

87

Ambucetamide

88

Ambutonium

89

Amcinonide

90

Amethocaine; for internal use; for external use in medicines containing more than 10%; for ophthalmic use except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

91

Amfebutamone

92

Amfepramone

93

Amidopyrine

94

Amifostine

95

Amikacin

96

Amiloride

97

Aminocaproic acid

98

Aminoglutethimide

99

Aminometradine

100

Aminophenazone; at all strengths

101

Aminophylline; except for oral use in liquid form in medicines containing 2% or less

102

Aminopterin

103

Aminorex

104

Aminosalicylic acid

105

Amiodarone

106

Amiphenazole

107

Amisometradine

108

Amisulpride

109

Amitriptyline

110

Amlodipine

111

Ammi visnaga

112

Ammonium bromide

113

Amobarbital

114

Amodiaquine

115

Amorolfine; except when specified elsewhere in this schedule; except in preparations for the treatment of tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

116

Amoxapine

117

Amoxycillin

118

Amphomycin

119

Amphotericin

120

Ampicillin

121

Amprenavir

122

Amrinone

123

Amsacrine

124

Amygdalin; at all strengths

125

Amyl nitrite; except when sold to a person who holds a controlled substances licence (issued under section 95B of the Hazardous Substances and New Organisms Act 1996) authorising the person to possess cyanide; except when sold to an exempt laboratory covered by a Hazardous Substances and New Organisms Act 1996 approved code of practice

126

Amylocaine

127

Anabolic steroids

128

Anagrelide

129

Anakinra

130

Anastrozole

131

Ancestim

132

Anchusa officinalis; at all strengths

133

Ancrod and its immunoglobulin antidote

134

Androgenic and anabolic steroidal agents

135

Androgens

136

Androisoxazole

137

Androstanolone

138

Androstenediol

139

Androstenedione

140

Anecortave

141

Angiotensinamide

142

Anidulafungin

143

Anistreplase

144

Antazoline; except for ophthalmic use

145

Antibiotic substances; except when specified elsewhere in this schedule

146

Antigens

147

Antihistamines; except when specified elsewhere in this schedule

148

Antimony; except in medicines containing 1 milligram or less per litre or per kilogram

149

Antisera; for injection

150

Apixaban

151

Apocynum spp

152

Apomorphine; except in medicines containing 1 milligram or less per litre or per kilogram

153

Apraclonidine

154

Aprepitant

155

Apronal

156

Aprotinin

157

Arecoline

158

Aripiprazole

159

Aristolochia spp; at all strengths

160

Aristolochic acid; at all strengths

161

Arsenic; except in medicines containing 1 milligram or less per litre or per kilogram

162

Artemether

163

Articaine; except when used as a local anaesthetic in practice by a dental therapist registered with the Dental Council

164

Asenapine

165

Asparaginase

166

Aspirin; for injection; when combined with caffeine, paracetamol, or salicylamide

167

Astemizole

168

Atamestane

169

Atazanavir

170

Atenolol

171

Atomoxetine

172

Atorvastatin

173

Atosiban

174

Atovaquone

175

Atracurium

176

Atropa belladonna; except when specified elsewhere in this schedule; except in medicines containing 300 micrograms or less of total solanaceous alkaloids per litre or per kilogram

177

Atropine; except when specified elsewhere in this schedule; except when used as an antidote in a device designed for self-injection; except in medicines containing 300 micrograms or less per litre or per kilogram

178

Atropine methonitrate

179

Auranofin

180

Aurothiomalate sodium

181

Avanafil

182

Aviptadil

183

Axitinib

184

Azacitidine

185

Azacyclonol

186

Azapropazone

187

Azaribine

188

Azatadine; except when specified elsewhere in this schedule

189

Azathioprine

190

Azelaic acid; except for dermal use

191

Azelastine; except when specified elsewhere in this schedule

192

Azithromycin

193

Azlocillin

194

Aztreonam

195

Bacampicillin

196

Bacitracin

197

Baclofen

198

Balsalazide

199

Bambuterol

200

Bamethan

201

Bamipine

202

Barbital

203

Barbiturates

204

Basiliximab

205

Bazedoxifene

206

Becaplermin

207

Beclamide

208

Beclomethasone; except when specified elsewhere in this schedule

209

Belatacept

210

Belimumab

211

Bemegride

212

Benactyzine

213

Benazepril

214

Bendamustine

215

Bendrofluazide

216

Benethamine penicillin

217

Benorylate

218

Benoxaprofen

219

Benperidol

220

Benserazide

221

Benzathine penicillin

222

Benzatropine

223

Benzhexol

224

Benzilonium

225

Benzocaine; except when specified elsewhere in this schedule; except in dermal preparations containing 2% or less of total anaesthetic substances; except in lozenges containing 30 milligrams or less of total anaesthetic substances per dosage unit

226

Benzodiazepines

227

Benzoyl metronidazole

228

Benzoyl peroxide; except for external use in medicines containing 10% or less

229

Benzthiazide

230

Benzydamine; for internal use

231

Benzylpenicillin

232

Bepridil

233

Beractant

234

Besifloxacin

235

Beta carotene; in medicines containing more than 18 milligrams per recommended daily dose

236

Betahistine

237

Betamethasone

238

Betaxolol

239

Bethanechol

240

Bethanidine

241

Bevacizumab

242

Bevantolol

243

Bexarotene

244

Bezafibrate

245

Bicalutamide

246

Bifonazole; except for dermal use

247

Bimatoprost

248

Biperiden

249

Bismuth; except for external use in medicines containing 3% or less

250

Bisoprolol

251

Bithionol; at all strengths

252

Bivalirudin

253

Bleomycin

254

Boceprevir

255

Bolandiol

256

Bolasterone

257

Bolazine

258

Boldenone

259

Bolenol

260

Bolmantalate

261

Boron, including borax and boric acid; except for internal use in medicines containing 6 milligrams or less per recommended daily dose; except in dermal medicines for use other than paediatric use containing 0.35% or less; except when present as an excipient

262

Bortezomib

263

Bosentan

264

Botulinum toxins

265

Bretylium

266

Brimonidine

267

Brinzolamide

268

Bromazepam

269

Bromocriptine

270

Bromoform

271

Brompheniramine; except when specified elsewhere in this schedule

272

Bromvaletone

273

Brotizolam

274

Brugmansia spp

275

Buclizine; except for oral use

276

Budesonide; except when specified elsewhere in this schedule

277

Bufexamac; except in suppositories or for dermal use in medicines containing 5% or less

278

Bumetanide

279

Buniodyl sodium; at all strengths

280

Buphenine

281

Bupivacaine

282

Buprenorphine

283

Bupropion

284

Buserelin

285

Buspirone

286

Busulphan

287

Butacaine

288

Butobarbital

289

Butoconazole; except for vaginal use

290

Butorphanol

291

Butyl aminobenzoate; except for dermal use in medicines containing 2% or less

292

Butyl nitrite

293

Butylchloral hydrate

294

Cabazitaxel

295

Cabergoline

296

Cacalia spp; at all strengths

297

Cadmium

298

Calcipotriol; except in medicines containing not more than 50 micrograms per gram or per millilitre and when sold in a pack of not more than 30 grams or 30 millilitres by a pharmacist to an adult with mild to moderate psoriasis previously diagnosed by a doctor

299

Calcitonin

300

Calcitriol

301

Calcium carbimide

302

Calcium polystyrene sulphonate

303

Calotropis gigantea

304

Calotropis procera

305

Calusterone

306

Camazepam

307

Camphorated oil

308

Camphotamide

309

Canagliflozin

310

Canakinumab

311

Candesartan

312

Candicidin

313

Cannabidiol

314

Capecitabine

315

Capreomycin

316

Captodiame

317

Captopril

318

Capuride

319

Caramiphen

320

Carbachol

321

Carbamazepine

322

Carbaryl; except for external use in medicines containing 2% or less

323

Carbazochrome

324

Carbenicillin

325

Carbenoxolone; for internal use

326

Carbetocin

327

Carbidopa

328

Carbimazole

329

Carbocromen

330

Carboplatin

331

Carboprost

332

Carbromal

333

Carbutamide

334

Carbuterol

335

Carindacillin

336

Carisoprodol

337

Carmustine

338

Carprofen

339

Carvedilol

340

Caspofungin

341

Catumaxomab

342

Cefacetrile

343

Cefaclor

344

Cefaloridine

345

Cefamandole

346

Cefapirin

347

Cefazolin

348

Cefepime

349

Cefetamet

350

Cefixime

351

Cefodizime

352

Cefonicid

353

Cefoperazone

354

Cefotaxime

355

Cefotetan

356

Cefotiam

357

Cefoxitin

358

Cefpirome

359

Cefpodoxime

360

Cefsulodin

361

Ceftaroline fosamil

362

Ceftazidime

363

Ceftibuten

364

Ceftolozane

365

Ceftriaxone

366

Cefuroxime

367

Celecoxib

368

Celiprolol

369

Cephaelis acuminata; except in medicines containing less than 0.2% of emetine

370

Cephaelis ipecacuanha; except in medicines containing less than 0.2% of emetine

371

Cephalexin

372

Cephalothin

373

Cephradine

374

Cerivastatin

375

Certolizumab pegol

376

Ceruletide

377

Cetirizine; except for oral use

378

Cetrorelix

379

Cetuximab

380

Chenodeoxycholic acid

381

Chloral hydrate; except for dermal use in medicines containing 2% or less

382

Chloralformamide

383

Chloralose

384

Chlorambucil

385

Chloramphenicol; except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; except when specified elsewhere in this schedule

386

Chlorandrostenolone

387

Chlorazanil

388

Chlorcyclizine

389

Chlordiazepoxide

390

Chlormerodrin

391

Chlormethiazole

392

Chlormezanone

393

Chloroform; for anaesthesia; except when specified elsewhere in this schedule

394

Chloroquine

395

Chlorothiazide

396

Chlorotrianisene

397

Chloroxydienone

398

Chloroxymesterone

399

Chlorpheniramine; except when specified elsewhere in this schedule

400

Chlorphentermine

401

Chlorpromazine

402

Chlorpropamide

403

Chlorprothixene

404

Chlorquinaldol

405

Chlortetracycline

406

Chlorthalidone

407

Chlorzoxazone

408

Cholera vaccine; except in the form of an oral liquid containing vibrio cholerae when sold in a pharmacy by a registered pharmacist

409

Choline salicylate; except in medicines containing 10% or less and in pack sizes of 15 grams or less

410

Chorionic gonadotrophin; except in pregnancy test kits

411

Chymopapain

412

Ciclacillin

413

Ciclesonide

414

Ciclopirox; except for external use

415

Cidofovir

416

Cilastatin

417

Cilazapril

418

Cilostazol

419

Cimetidine; except when specified elsewhere in this schedule

420

Cinacalcet

421

Cinchocaine; for injection; for ophthalmic use; for external use in medicines containing more than 0.5%

422

Cinchophen

423

Cinoxacin

424

Ciprofloxacin

425

Cisapride

426

Cisatracurium

427

Cisplatin

428

Citalopram

429

Cladribine

430

Clarithromycin

431

Clavulanic acid

432

Clemastine; except for oral use

433

Clemizole

434

Clenbuterol

435

Clevidipine

436

Clidinium

437

Clindamycin

438

Clioquinol; at all strengths

439

Clobazam

440

Clobetasol

441

Clobetasone; except when specified elsewhere in this schedule

442

Clocortolone

443

Clodronic acid

444

Clofarabine

445

Clofazimine

446

Clofenamide

447

Clofibrate

448

Clomiphene

449

Clomipramine

450

Clomocycline

451

Clonazepam

452

Clonidine

453

Clopamide

454

Clopidogrel

455

Clorexolone

456

Clorprenaline

457

Clostebol

458

Clotiazepam

459

Clotrimazole; except in medicines for vaginal or external use

460

Cloxacillin

461

Cloxazolam

462

Clozapine

463

Cobalt

464

Cobicistat

465

Cocaine; except when specified elsewhere in this schedule

466

Codeine; except when specified elsewhere in this schedule

467

Co-dergocrine

468

Colaspase

469

Colchicine

470

Colchicum

471

Colecalciferol; in medicines containing more than 25 micrograms per recommended daily dose except in parenteral nutrition replacement preparations

472

Colestipol

473

Colestyramine

474

Colfosceril

475

Colistin

476

Collagen; in injections or implants for tissue augmentation or cosmetic use

477

Collagenase clostridium histolyticum

478

Conium maculatum; at all strengths

479

Convallaria keiski

480

Convallaria majalis

481

Corifollitropin alfa

482

Coronilla spp

483

Corticosterone

484

Corticotrophin

485

Cortisone and other steroidal hormones of the adrenal cortex; except when specified elsewhere in this schedule; except adrenal extract for dermal use in medicines containing 0.02% or less of ketosteroids

486

Cotarnine; at all strengths

487

Co-trimoxazole

488

Coumarin

489

Crizotinib

490

Crofelemer

491

Crotalaria spp; at all strengths

492

Croton tiglium; except in medicines containing 1 milligram or less per litre or per kilogram

493

Crystal violet

494

Curare

495

Cyclandelate

496

Cyclizine; except when specified elsewhere in this schedule

497

Cyclobenzaprine

498

Cyclofenil

499

Cycloheximide

500

Cyclopenthiazide

501

Cyclopentolate; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

502

Cyclophosphamide

503

Cyclopropane

504

Cycloserine

505

Cyclosporin

506

Cyclothiazide

507

Cycrimine

508

Cymarin

509

Cynoglossum spp; at all strengths

510

Cyproheptadine; except for oral use

511

Cyproterone

512

Cysteamine

513

Cytarabine

514

Dabigatran

515

Dabrafenib mesilate

516

Dacarbazine

517

Daclizumab

518

Dactinomycin

519

Dalfopristin

520

Dalteparin

521

Danaparoid

522

Danazol

523

Danthron

524

Dantrolene

525

Dapagliflozin

526

Dapoxetine

527

Dapsone

528

Daptomycin

529

Darbepoetin

530

Darifenacin

531

Darunavir

532

Dasabuvir

533

Dasatinib

534

Datura spp; except for oral use when specified elsewhere in this schedule; except datura stramonium or datura tatula for smoking or burning

535

Daunorubicin

536

Deanol

537

Debrisoquine

538

Decamethonium

539

Deferasirox

540

Deferiprone

541

Deflazacort

542

Degarelix

543

Dehydrochloromethyltestosterone

544

Dehydrocorticosterone

545

Delavirdine

546

Delorazepam

547

Demecarium

548

Demeclocycline

549

Denosumab

550

Deoxycortone

551

Deoxyribonuclease; except for external use

552

Desferrioxamine

553

Desflurane

554

Desipramine

555

Desirudin

556

Deslanoside

557

Desloratadine; except for oral use

558

Deslorelin

559

Desmopressin

560

Desogestrel

561

Desonide

562

Desoximetasone

563

Desvenlafaxine

564

Dexamethasone

565

Dexamfetamine

566

Dexchlorpheniramine; except when specified elsewhere in this schedule

567

Dexfenfluramine

568

Dexmedetomidine

569

Dextromethorphan; except when specified elsewhere in this schedule

570

Dextromoramide

571

Dextropropoxyphene

572

Dextrorphan

573

Di-iodohydroxy quinoline; except for vaginal use

574

Di-isopropylamine dichloroacetate

575

Diazepam

576

Diazoxide

577

Dibenzepin

578

Dibotermin

579

Dibrompropamidine; except for ophthalmic use

580

Dichloralphenazone

581

Dichlorophen

582

Dichlorphenamide

583

Diclofenac; in preparations for the treatment of solar keratosis; except when specified elsewhere in this schedule; except in preparations for external use other than for the treatment of solar keratosis

584

Dicloxacillin

585

Dicyclomine

586

Didanosine

587

Dienoestrol

588

Dienogest

589

Diethazine

590

Diethylcarbamazine

591

Diethylstilbestrol

592

Diflorasone

593

Diflucortolone

594

Diflunisal

595

Digitalis lanata

596

Digitalis purpurea

597

Digitoxin

598

Digoxin

599

Digoxin-specific antibody fragment

600

Dihydralazine

601

Dihydrocodeine

602

Dihydroergotoxine

603

Dihydrolone

604

Dihydrotachysterol

605

Diltiazem

606

Dimenhydrinate; except when specified elsewhere in this schedule

607

Dimercaprol

608

Dimethandrostanolone

609

Dimethazine

610

Dimethindene; except for oral use

611

Dimethothiazine

612

Dimethoxanate

613

Dimethyl fumarate

614

Dimethyl sulphoxide

615

Dinitrocresols

616

Dinitronaphthols

617

Dinitrophenols

618

Dinitrothymols

619

Dinoprost

620

Dinoprostone

621

Diperodon

622

Diphemanil; except for dermal use

623

Diphenhydramine; except when specified elsewhere in this schedule

624

Diphenidol

625

Diphenoxylate; except when specified elsewhere in this schedule

626

Diphenylpyraline

627

Diphtheria, tetanus and pertussis (acellular, component) vaccine; except when administered in a single dose to a person 18 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

628

Diphtheria toxoid

629

Diphtheria vaccine

630

Dipivefrin

631

Dipyridamole

632

Dirithromycin

633

Disopyramide

634

Distigmine

635

Disulfiram

636

Disulphamide

637

Ditiocarb

638

Dobutamine

639

Docetaxel

640

Dofetilide

641

Dolasetron

642

Dolutegravir

643

Domperidone

644

Donepezil

645

Dopamine

646

Dopexamine

647

Doripenem

648

Dornase

649

Dorzolamide

650

Dothiepin

651

Doxantrazole

652

Doxapram

653

Doxazosin

654

Doxepin

655

Doxorubicin

656

Doxycycline

657

Doxylamine; except when specified elsewhere in this schedule

658

Dronedarone

659

Droperidol

660

Drospirenone

661

Drostanolone

662

Drotrecogin

663

Duboisia leichhardtii; except when specified elsewhere in this schedule

664

Duboisia myoporides; except when specified elsewhere in this schedule

665

Dulcin; at all strengths

666

Duloxetine

667

Dutasteride

668

Dydrogesterone

669

Econazole; except in medicines for vaginal or dermal use

670

Ecothiopate

671

Ectylurea

672

Eculizumab

673

Edetic acid; in medicines containing more than 0.25%; except in contact lens preparations; except dicobalt edetate for the treatment of cyanide poisoning

674

Edoxudine

675

Edrophonium

676

Efalizumab

677

Efavirenz

678

Eflornithine

679

Eletriptan

680

Eltrombopag olamine

681

Elvitegravir

682

Emepronium

683

Emetine; in medicines containing more than 0.2%

684

Empagliflozin

685

Emtricitabine

686

Enalapril

687

Enestebol

688

Enflurane

689

Enfuvirtide

690

Enobosarm

691

Enoxacin

692

Enoxaparin

693

Enoximone

694

Enprostil

695

Entacapone

696

Entecavir

697

Enzalutamide

698

Ephedrine

699

Epicillin

700

Epinastine

701

Epirubicin

702

Epitiostanol

703

Eplerenone

704

Epoetins

705

Epoprostenol

706

Eprosartan

707

Eptifibatide

708

Ergocalciferol; in medicines containing more than 25 micrograms per recommended daily dose

709

Ergometrine

710

Ergot

711

Ergotamine

712

Ergotoxine

713

Eribulin

714

Erlotinib

715

Ertapenem

716

Erysimum spp; except in medicines containing 1 milligram or less per litre or per kilogram

717

Erythromycin

718

Erythropoietin

719

Escitalopram

720

Esmolol

721

Esomeprazole

722

Estazolam

723

Estramustine

724

Estropipate

725

Etanercept

726

Ethacrynic acid

727

Ethambutol

728

Ethamivan

729

Ethanolamine; for injection

730

Ethchlorvynol

731

Ether; for anaesthesia

732

Ethinamate

733

Ethinyloestradiol

734

Ethionamide

735

Ethisterone

736

Ethoglucid

737

Ethoheptazine

738

Ethopropazine

739

Ethosuximide

740

Ethotoin

741

Ethoxzolamide

742

Ethyl chloride; for inhalation

743

Ethyl loflazepate

744

Ethyldienolone

745

Ethylhexanediol; at all strengths

746

Ethyloestrenol

747

Ethynodiol

748

Etidocaine

749

Etidronic acid; except in medicines for external use containing 1% or less

750

Etilefrine

751

Etodolac

752

Etofenamate; except for external use

753

Etonogestrel

754

Etoposide

755

Etoricoxib

756

Etravirine

757

Etretinate

758

Everolimus

759

Exemestane

760

Exenatide

761

Ezetimibe

762

Factor VIII inhibitor bypassing fraction

763

Famciclovir; except when specified elsewhere in this schedule

764

Famotidine; except when specified elsewhere in this schedule

765

Fampridine

766

Farfugium japonicum; at all strengths

767

Febuxostat

768

Felbinac; except for external use

769

Felodipine

770

Felypressin; except when combined with a local anaesthetic and used in practice by a dental therapist registered with the Dental Council

771

Fenbufen

772

Fenclofenac

773

Fenfluramine

774

Fenofibrate

775

Fenoldopam

776

Fenoprofen

777

Fenoterol

778

Fenpipramide

779

Fenpiprane

780

Fentanyl

781

Ferric carboxymaltose

782

Fexofenadine; except for oral use

783

Fibrin

784

Fibrinolysin; except for external use

785

Fidaxomicin

786

Filgrastim

787

Finasteride

788

Fingolimod

789

Flecainide

790

Fleroxacin

791

Floctafenine

792

Fluanisone

793

Fluclorolone

794

Flucloxacillin

795

Fluconazole; except when specified elsewhere in this schedule

796

Flucytosine

797

Fludarabine

798

Fludiazepam

799

Fludrocortisone

800

Flufenamic acid

801

Flumazenil

802

Flumethasone

803

Flumethiazide

804

Flunisolide

805

Flunitrazepam

806

Fluocinolone

807

Fluocinonide

808

Fluocortin

809

Fluocortolone

810

Fluorescein; for injection

811

Fluorides; for internal use in medicines containing more than 0.5 milligrams per dose unit except in medicines containing 15 milligrams or less per litre or per kilogram; except in parenteral nutrition replacement preparations; for external use in medicines containing more than 5.5 grams per litre or per kilogram except when supplied to a dental professional registered with the Dental Council

812

Fluorometholone

813

Fluorouracil

814

Fluoxetine

815

Fluoxymesterone

816

Flupenthixol

817

Fluphenazine

818

Flurandrenolone

819

Flurazepam

820

Flurbiprofen; except in locally acting oromucosal preparations containing 10 milligrams or less per dosage unit

821

Fluroxene

822

Fluspirilene

823

Flutamide

824

Fluticasone; except when specified elsewhere in this schedule

825

Fluvastatin

826

Fluvoxamine

827

Folic acid; for injection except in parenteral nutrition replacement preparations

828

Folinic acid; for injection

829

Follicle-stimulating hormone; except in medicines containing 100 micrograms or less per litre or per kilogram

830

Follistatin

831

Follitropin

832

Fomivirsen

833

Fondaparinux

834

Formebolone

835

Formestane

836

Formoterol

837

Fosamprenavir

838

Fosaprepitant

839

Foscarnet

840

Fosfestrol

841

Fosinopril

842

Fosphenytoin

843

Fotemustine

844

Framycetin

845

Fulvestrant

846

Furaltadone

847

Furazabol

848

Furazolidone

849

Furosemide

850

Fusidic acid

851

Gabapentin

852

Galantamine

853

Galanthus spp

854

Gallamine

855

Galsulfase

856

Ganciclovir

857

Ganirelix

858

Gatifloxacin

859

Gefitinib

860

Gemcitabine

861

Gemeprost

862

Gemfibrozil

863

Gemifloxacin

864

Gemtuzumab ozogamicin

865

Gentamicin

866

Gestodene

867

Gestonorone

868

Gestrinone

869

Ghrelin

870

Gitalin

871

Glatiramer acetate

872

Glibenclamide

873

Glibornuride

874

Gliclazide

875

Glimepiride

876

Glipizide

877

Glisoxepide

878

Glutathione; for injection

879

Glyceryl trinitrate; for injection; for transdermal use; except in medicines containing 100 micrograms or less per litre or per kilogram

880

Glycopyrronium

881

Glymidine

882

Golimumab

883

Gonadorelin

884

Gonadotrophic hormones; except when specified elsewhere in this schedule

885

Goserelin

886

Gramicidin

887

Granisetron

888

Grepafloxacin

889

Griseofulvin

890

Guaiphenesin; for oral use in medicines containing more than 2% or 200 milligrams per dose form except when specified elsewhere in this schedule; except for oral use in modified release form with a maximum recommended daily dose of not more than 2.4 grams when sold in the manufacturer’s original pack containing not more than 10 days’ supply

891

Guanabenz

892

Guanethidine

893

Guanidine

894

Hachimycin

895

Haematin

896

Haemophilus influenzae vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

897

Halazepam

898

Halcinonide

899

Halofantrine

900

Halofenate

901

Haloperidol; except in medicines containing 1 milligram or less per litre or per kilogram

902

Halothane

903

Haloxazolam

904

Halquinol; for internal use

905

Heliotropium spp; at all strengths

906

Hemerocallis

907

Heparins; for internal use; except when present as an excipient

908

Hepatitis A vaccine

909

Hepatitis B vaccine

910

Hetacillin

911

Hexachlorophane; in medicines containing more than 3%

912

Hexamethonium

913

Hexarelin

914

Hexetidine; for internal use

915

Hexobendine

916

Hexocyclium

917

Hexoprenaline

918

Histamine; in medicines containing more than 0.5%

919

Homatropine

920

Human chorionic gonadotrophin; except in pregnancy test kits

921

Human growth hormone secretagogues

922

Human papillomavirus vaccine

923

Human protein C

924

Hyaluronic acid; in injections or implants for tissue augmentation or cosmetic use

925

Hydralazine

926

Hydrargaphen

927

Hydrochlorothiazide

928

Hydrocortisone; except when specified elsewhere in this schedule

929

Hydrocyanic acid; except when specified elsewhere in this schedule; except in medicines containing 1 microgram or less per litre or per kilogram

930

Hydroflumethiazide

931

Hydromorphone

932

Hydroquinone; except in medicines for external use containing 2% or less

933

Hydroxychloroquine

934

Hydroxyephedrine

935

Hydroxyphenamate

936

Hydroxyprogesterone

937

Hydroxystenozol

938

Hydroxyurea

939

Hydroxyzine

940

Hylan polymer; in injections or implants for tissue augmentation or cosmetic use

941

Hyoscine; except when specified elsewhere in this schedule; except in medicines containing 300 micrograms or less per litre or per kilogram

942

Hyoscine butylbromide; except when specified elsewhere in this schedule

943

Hyoscyamine; except when specified elsewhere in this schedule; except in medicines containing 300 micrograms or less per litre or per kilogram

944

Hyoscyamus niger; except when specified elsewhere in this schedule; except in medicines containing 300 micrograms or less of total solanaceous alkaloids per litre or per kilogram

945

Hypothalamic releasing factors

946

Hypromellose; for injection; except in intraocular viscoelastic products

947

Ibandronic acid

948

Ibogaine

949

Ibritumomab tiuxetan

950

Ibrutinib

951

Ibufenac

952

Ibuprofen; except when specified elsewhere in this schedule

953

Ibuterol

954

Ibutilide

955

Icatibant

956

Idarubicin

957

Idoxuridine; except for dermal use in medicines containing 0.5% or less

958

Idursulfase

959

Ifosfamide

960

Iloprost

961

Imatinib

962

Imiglucerase

963

Imipenem

964

Imipramine

965

Imiquimod

966

Immunoglobulins

967

Indacaterol

968

Indapamide

969

Indinavir

970

Indomethacin; except for external use in medicines containing 1% or less; except in medicines containing 1 milligram or less per litre or per kilogram

971

Indoprofen

972

Indoramin

973

Infliximab

974

Influenza and coryza vaccines; for injection; for nasal use

975

Influenza vaccine; except when administered to a person 18 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

976

Ingenol mebutate

977

Insulin-like growth factors; except when specified elsewhere in this schedule

978

Insulins

979

Interferons

980

Interleukins

981

Iodothiouracil

982

Ipamorelin

983

Ipecacuanha; except in medicines containing less than 0.2% of emetine

984

Ipilimumab

985

Ipratropium; except for nasal use

986

Ipriflavone

987

Iprindole

988

Iproniazid

989

Irbesartan

990

Irinotecan

991

Iron; for injection except in parenteral nutrition replacement preparations

992

Isoaminile

993

Isoamyl nitrite

994

Isobutyl nitrite

995

Isocarboxazid

996

Isoconazole; except in medicines for vaginal or dermal use

997

Isoetarine

998

Isoflurane

999

Isometheptene

1000

Isoniazid

1001

Isoprenaline

1002

Isoprinosine

1003

Isopropamide; except for dermal use in preparations containing 2% or less

1004

Isosorbide dinitrate

1005

Isosorbide mononitrate

1006

Isotretinoin

1007

Isoxicam

1008

Isoxsuprine

1009

Isradipine

1010

Itraconazole

1011

Ivabradine

1012

Ivacaftor

1013

Ivermectin

1014

Ixabepilone

1015

Japanese encephalitis vaccine

1016

Juniperus sabina; at all strengths

1017

Kanamycin

1018

Ketamine

1019

Ketanserin

1020

Ketazolam

1021

Ketoconazole; except for dermal use

1022

Ketoprofen; except when specified elsewhere in this schedule; except for dermal use

1023

Ketorolac

1024

Ketotifen; except for ophthalmic use in medicines containing 0.025% or less

1025

Khellin

1026

Labetalol

1027

Lacidipine

1028

Lacosamide

1029

Lamivudine

1030

Lamotrigine

1031

Lanatosides

1032

Lanreotide

1033

Lansoprazole; except when specified elsewhere in this schedule

1034

Lanthanum

1035

Lapatinib

1036

Laronidase-rch

1037

Laropiprant

1038

Latamoxef

1039

Latanoprost

1040

Laudexium

1041

Lauromacrogols; for injection

1042

Lead

1043

Ledipasvir

1044

Lefetamine

1045

Leflunomide

1046

Lenalidomide

1047

Lenograstim

1048

Lepirudin

1049

Leptazol

1050

Lercanidipine

1051

Letrozole

1052

Leucovorin; for injection

1053

Leuprorelin

1054

Levallorphan

1055

Levamisole

1056

Levetiracetam

1057

Levobunolol

1058

Levobupivacaine

1059

Levocabastine; except for nasal or ophthalmic use

1060

Levocetirizine; except for oral use

1061

Levodopa

1062

Levomepromazine

1063

Levonorgestrel; except when specified elsewhere in this schedule; except in medicines for use as emergency post-coital contraception when sold by nurses recognised by their professional body as having competency in the field of sexual and reproductive health

1064

Levosimendan

1065

Lidoflazine

1066

Lignocaine; for injection except when used as a local anaesthetic in practice by a nurse whose scope of practice permits the performance of general nursing functions or by a podiatrist registered with the Podiatrists Board or dental therapist registered with the Dental Council; for oral use except in throat lozenges containing 30 milligrams or less per dose form; for ophthalmic use except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; for external use in medicines containing more than 10%

1067

Ligularia dentata; at all strengths

1068

Linagliptin

1069

Lincomycin

1070

Lindane; except for external use in medicines containing 2% or less

1071

Linezolid

1072

Liothyronine

1073

Liraglutide

1074

Lisinopril

1075

Lisuride

1076

Lithium; except when specified elsewhere in this schedule; except when present as an excipient in dermal medicines containing 0.25% or less

1077

Lixisenatide

1078

Lodoxamide; except in medicines for ophthalmic use

1079

Lofexidine

1080

Lomefloxacin

1081

Lomustine

1082

Loperamide; except when specified elsewhere in this schedule

1083

Lopinavir

1084

Loprazolam

1085

Loracarbef

1086

Loratadine; except for oral use

1087

Lorazepam

1088

Lormetazepam

1089

Losartan

1090

Loteprednol

1091

Lovastatin; except when present as an unmodified, naturally occurring substance in a food that has not been subject to a manufacturing process other than heating, freezing, drying, preserving, bottling, canning, or packaging in retort pouches

1092

Loxapine

1093

Lumefantrine

1094

Lumiracoxib

1095

Lurasidone

1096

Luteinising hormone

1097

Lymecycline

1098

Macitentan

1099

Mafenide

1100

Mannomustine

1101

Maprotiline

1102

Maraviroc

1103

Mazindol

1104

Measles vaccine

1105

Mebanazine

1106

Mebeverine

1107

Mebhydrolin

1108

Mebolazine

1109

Mebutamate

1110

Mecamylamine

1111

Mecasermin

1112

Mecillinam

1113

Meclocycline

1114

Meclofenamate

1115

Meclofenoxate

1116

Meclozine; except when specified elsewhere in this schedule

1117

Medazepam

1118

Medigoxin

1119

Medroxyprogesterone

1120

Medrysone

1121

Mefenamic acid; except when specified elsewhere in this schedule

1122

Mefloquine

1123

Mefruside

1124

Megestrol

1125

Melagatran

1126

Melanocyte stimulating compounds

1127

Melatonin

1128

Melengestrol

1129

Melia azedarach; at all strengths

1130

Meloxicam

1131

Melphalan

1132

Memantine

1133

Meningococcal vaccine; except when administered to a person 16 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

1134

Menotrophin

1135

Mepacrine

1136

Mepenzolate

1137

Mephenesin

1138

Mephentermine

1139

Mepindolol

1140

Mepitiostane

1141

Mepivacaine

1142

Meprobamate

1143

Meptazinol

1144

Mepyramine; except when specified elsewhere in this schedule

1145

Mequitazine

1146

Mercaptomerin

1147

Mercaptopurine

1148

Mercurochrome; except when specified elsewhere in this schedule

1149

Mercury; except when specified elsewhere in this schedule; except in medicines containing 1 milligram or less per litre or per kilogram

1150

Meropenem

1151

Mersalyl

1152

Mesabolone

1153

Mesalazine

1154

Mesna

1155

Mestanolone

1156

Mesterolone

1157

Mestranol

1158

Metamfetamine

1159

Metandienone

1160

Metaraminol

1161

Metenolone

1162

Metergoline

1163

Metformin

1164

Methacholine

1165

Methacycline

1166

Methadone

1167

Methallenoestril

1168

Methandriol

1169

Methanthelinium

1170

Methazolamide

1171

Methdilazine; except for oral use

1172

Methicillin

1173

Methimazole

1174

Methisazone

1175

Methixene

1176

Methocarbamol

1177

Methohexitone

1178

Methoin

1179

Methotrexate

1180

Methoxamine; except for external use

1181

Methoxsalen

1182

Methoxyflurane

1183

Methsuximide

1184

Methyclothiazide

1185

Methyl aminolevulinate

1186

Methyl androstanolone

1187

Methyl clostebol

1188

Methyl mercury; except in medicines containing 300 micrograms or less per litre or per kilogram

1189

Methyl salicylate; for internal use except when present as an excipient in medicines containing 1.04% or less per dose form

1190

Methyl trienolone

1191

Methyldopa

1192

Methylene blue; for injection

1193

Methylergometrine

1194

Methylnaltrexone

1195

Methylpentynol

1196

Methylphenidate

1197

Methylphenobarbital

1198

Methylprednisolone

1199

Methyltestosterone

1200

Methylthiouracil

1201

Methyprylon

1202

Methysergide

1203

Metoclopramide; except when specified elsewhere in this schedule

1204

Metolazone

1205

Metoprolol

1206

Metribolone

1207

Metrifonate

1208

Metronidazole

1209

Metyrapone

1210

Mexiletine

1211

Mezlocillin

1212

Mianserin

1213

Mibefradil

1214

Mibolerone

1215

Micafungin

1216

Miconazole; except when specified elsewhere in this schedule; except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

1217

Midazolam

1218

Midodrine

1219

Mifepristone

1220

Miglitol

1221

Miglustat

1222

Milrinone

1223

Minocycline

1224

Minoxidil; except for dermal use in medicines containing 5% or less

1225

Mirabegron

1226

Mirtazapine

1227

Misoprostol

1228

Mitobronitol

1229

Mitomycin

1230

Mitoxantrone

1231

Mitragyna speciosa

1232

Mitragynine

1233

Mivacurium

1234

Moclobemide

1235

Modafinil

1236

Molgramostim

1237

Molindone

1238

Mometasone; except when specified elsewhere in this schedule

1239

Monobenzone

1240

Monoclonal antibodies; except in pregnancy test kits

1241

Montelukast

1242

Moperone

1243

Morazone

1244

Moricizine

1245

Morphine; except when specified elsewhere in this schedule

1246

Motrazepam

1247

Motretinide

1248

Moxifloxacin

1249

Mumps vaccine

1250

Mupirocin

1251

Muraglitazar

1252

Muromonab

1253

Mustine

1254

Mycophenolic acid

1255

Nabilone

1256

Nabumetone

1257

Nadolol

1258

Nadroparin

1259

Nafarelin

1260

Naftidrofuryl

1261

Nalbuphine

1262

Nalidixic acid

1263

Nalmefene

1264

Nalorphine

1265

Naloxone

1266

Naltrexone

1267

Nandrolone

1268

Naproxen; except when specified elsewhere in this schedule

1269

Naratriptan

1270

Natalizumab

1271

Natamycin

1272

Nateglinide

1273

Nebacumab

1274

Nebivolol

1275

Nedocromil

1276

Nefazodone

1277

Nefopam

1278

Nelfinavir

1279

Neomycin

1280

Neostigmine

1281

Nepafenac

1282

Nerium oleander

1283

Nesiritide

1284

Netilmicin

1285

Nevirapine

1286

Nialamide

1287

Nicardipine

1288

Nicergoline

1289

Nicofuranose

1290

Nicorandil

1291

Nicotine; for nasal use except when sold from a smoking cessation clinic run under the auspices of a registered medical practitioner; in medicines other than for smoking cessation

1292

Nicotinic acid except nicotinamide; in medicines containing more than 250 milligrams per dose form

1293

Nicoumalone

1294

Nifedipine

1295

Nifenazone

1296

Nikethamide

1297

Nilotinib

1298

Nilutamide

1299

Nimesulide

1300

Nimetazepam

1301

Nimodipine

1302

Nimorazole

1303

Nintedanib

1304

Niridazole

1305

Nisoldipine

1306

Nitisinone

1307

Nitrazepam

1308

Nitrendipine

1309

Nitric oxide

1310

Nitrofurantoin

1311

Nitrofurazone

1312

Nitrous oxide; when supplied for inhalation

1313

Nitroxoline

1314

Nizatidine; except when specified elsewhere in this schedule

1315

Nomegestrol

1316

Nomifensine

1317

Noradrenaline

1318

Norandrostenolone

1319

Norbolethone

1320

Norclostebol

1321

Nordazepam

1322

Norelgestromin

1323

Norethandrolone

1324

Norethisterone

1325

Norfloxacin

1326

Norgestrel

1327

Noribogaine

1328

Normethandrone

1329

Nortriptyline

1330

Noxiptyline

1331

Nux vomica; except in medicines containing 1 milligram or less per litre or per kilogram of strychnine

1332

Nystatin; except when specified elsewhere in this schedule; except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

1333

Obinutuzumab

1334

Ocriplasmin

1335

Octamylamine

1336

Octatropine

1337

Octreotide

1338

Octyl nitrite

1339

Oestradiol; except in medicines containing 10 micrograms or less per litre or per kilogram

1340

Oestriol

1341

Oestrogens

1342

Oestrone; except in medicines containing 1 milligram or less per litre or per kilogram

1343

Ofatumumab

1344

Ofloxacin

1345

Olanzapine

1346

Oleandomycin

1347

Oleandrin

1348

Olmesartan

1349

Olodaterol

1350

Olopatadine

1351

Olsalazine

1352

Omalizumab

1353

Ombitasvir

1354

Omeprazole; except when specified elsewhere in this schedule

1355

Ondansetron

1356

Opipramol

1357

Opium; except when specified elsewhere in this schedule

1358

Orciprenaline

1359

Orlistat; except in medicines for weight control containing 120 milligrams or less per dose form

1360

Ornidazole

1361

Ornipressin

1362

Orphenadrine

1363

Orthopterin

1364

Oseltamivir; except when specified elsewhere in this schedule

1365

Ouabain

1366

Ovandrotone

1367

Oxabolone

1368

Oxacillin

1369

Oxaliplatin

1370

Oxandrolone

1371

Oxaprozin

1372

Oxazepam

1373

Oxazolam

1374

Oxcarbazepine

1375

Oxedrine; in medicines containing more than 30 milligrams per recommended daily dose

1376

Oxetacaine; except for internal use

1377

Oxiconazole; except when specified elsewhere in this schedule

1378

Oxitropium

1379

Oxolamine

1380

Oxolinic acid

1381

Oxpentifylline

1382

Oxprenolol

1383

Oxybuprocaine; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

1384

Oxybutynin

1385

Oxycodone

1386

Oxymesterone

1387

Oxymetholone

1388

Oxyphenbutazone

1389

Oxyphencyclimine

1390

Oxyphenisatin; at all strengths

1391

Oxyphenonium

1392

Oxytetracycline

1393

Oxytocin; except in medicines containing 1 microgram or less per litre or per kilogram

1394

Paclitaxel

1395

Palifermin

1396

Paliperidone

1397

Palivizumab

1398

Palonosetron

1399

Pamaquin

1400

Pamidronic acid

1401

Pancreatic enzymes; in medicines containing more than 20 000 BP units of lipase activity

1402

Pancuronium

1403

Panitumumab

1404

Pantoprazole; except when specified elsewhere in this schedule

1405

Papaveretum

1406

Papaverine; for injection

1407

Paracetamol; except when specified elsewhere in this schedule

1408

Paraldehyde

1409

Paramethadione

1410

Paramethasone

1411

Parecoxib

1412

Paricalcitol

1413

Paromomycin

1414

Paroxetine

1415

Pasireotide

1416

Pazopanib

1417

Pecazine

1418

Pefloxacin

1419

Pegaptanib

1420

Pegfilgrastim

1421

Peginterferon

1422

Pegvisomant

1423

Pemetrexed

1424

Pemoline

1425

Pempidine

1426

Penbutolol

1427

Penciclovir; except for external use for the treatment of herpes labialis

1428

Penicillamine

1429

Pentaerythrityl tetranitrate

1430

Pentagastrin

1431

Pentamethonium

1432

Pentamidine

1433

Pentazocine

1434

Penthienate

1435

Pentolinium

1436

Pentosan polysulfate sodium

1437

Pentoxifylline

1438

Perampanel

1439

Pergolide

1440

Perhexiline

1441

Pericyazine

1442

Perindopril

1443

Permethrin; in medicines containing more than 5%

1444

Perphenazine

1445

Pertussis antigen

1446

Pertussis (whooping cough) vaccine

1447

Pertuzumab

1448

Pethidine

1449

Phenacemide

1450

Phenacetin; except when present as an excipient

1451

Phenaglycodol

1452

Phenazone; except for external use

1453

Phenazopyridine

1454

Phenelzine

1455

Pheneticillin

1456

Phenformin

1457

Phenglutarimide

1458

Phenindione

1459

Pheniramine; except when specified elsewhere in this schedule

1460

Phenisatin

1461

Phenobarbital

1462

Phenol; for injection

1463

Phenolphthalein

1464

Phenoperidine

1465

Phenoxybenzamine

1466

Phenoxymethylpenicillin

1467

Phensuximide

1468

Phentermine

1469

Phenthimentonium

1470

Phentolamine

1471

Phenylbutazone

1472

Phenylephrine; except when specified elsewhere in this schedule

1473

Phenylpropanolamine

1474

Phenyltoloxamine

1475

Phenytoin

1476

Pholcodine; except when specified elsewhere in this schedule

1477

Phosphodiesterase type 5 inhibitors; except when present as an unmodified, naturally occurring substance; except when specified elsewhere in this schedule

1478

Phthalylsulfathiazole

1479

Physostigmine

1480

Picric acid

1481

Picrotoxin

1482

Pilocarpine; except in medicines containing 0.025% or less

1483

Pimecrolimus

1484

Pimozide

1485

Pinacidil

1486

Pinazepam

1487

Pindolol

1488

Pioglitazone

1489

Pipecuronium

1490

Pipemidic acid

1491

Pipenzolate

1492

Piperacillin

1493

Piperidine

1494

Piperidolate

1495

Pipobroman

1496

Pipothiazine

1497

Pipradrol

1498

Piracetam

1499

Pirbuterol

1500

Pirenoxine

1501

Pirenzepine

1502

Piretanide

1503

Piroxicam; except for external use

1504

Pirprofen

1505

Pitavastatin

1506

Pituitary hormones

1507

Pivampicillin

1508

Pizotifen

1509

Plerixafor

1510

Plicamycin

1511

Pneumococcal vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

1512

Podophyllotoxin; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 1%; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

1513

Podophyllum emodi; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

1514

Podophyllum peltatum; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

1515

Polidexide

1516

Poliomyelitis vaccine

1517

Polyacrylamide; in injections or implants for tissue augmentation or cosmetic use

1518

Polyestradiol

1519

Polylactic acid; in injections or implants for tissue augmentation or cosmetic use

1520

Polymyxin

1521

Polysulfated glycosaminoglycans; for injection except in intraocular viscoelastic products

1522

Polythiazide

1523

Pomalidomide

1524

Poractant alfa

1525

Posaconazole

1526

Potassium bromide

1527

Potassium perchlorate

1528

Practolol

1529

Pradofloxacin

1530

Pralatrexate

1531

Pralidoxime

1532

Pramipexole

1533

Pramocaine

1534

Prampine

1535

Prasterone

1536

Prasugrel

1537

Pravastatin

1538

Prazepam

1539

Praziquantel

1540

Prazosin

1541

Prednisolone

1542

Prednisone

1543

Pregabalin

1544

Pregnenolone

1545

Prenalterol

1546

Prenylamine

1547

Prilocaine; for injection except when used as a local anaesthetic in practice by a dental therapist registered with the Dental Council; except when specified elsewhere in this schedule

1548

Primaquine

1549

Primidone

1550

Probenecid

1551

Probucol

1552

Procainamide

1553

Procaine

1554

Procaine penicillin

1555

Procarbazine

1556

Prochlorperazine; except when specified elsewhere in this schedule; except when sold for the treatment of nausea associated with emergency contraception by pharmacists or nurses accredited to sell levonorgestrel for emergency contraception

1557

Procyclidine; except for dermal use in medicines containing 5% or less

1558

Progesterone; except in medicines containing 1 milligram or less per litre or per kilogram

1559

Progestogens

1560

Proglumide

1561

Proguanil

1562

Prolintane

1563

Promazine

1564

Promethazine; except when specified elsewhere in this schedule

1565

Promoxolane

1566

Propafenone

1567

Propamidine; except for ophthalmic use

1568

Propanidid

1569

Propantheline

1570

Propetandrol

1571

Propionibacterium acnes

1572

Propofol

1573

Propranolol; except in medicines containing 1 milligram or less per litre or per kilogram

1574

Propylthiouracil

1575

Propyphenazone

1576

Proquazone

1577

Proscillaridin

1578

Prostaglandins

1579

Protamine

1580

Prothionamide

1581

Prothipendyl

1582

Protirelin

1583

Protoveratrines

1584

Protriptyline

1585

Proxymetacaine; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

1586

Prucalopride

1587

Pseudoephedrine

1588

Pulmonaria spp; at all strengths

1589

Pyrazinamide

1590

Pyridinolcarbamate

1591

Pyridostigmine

1592

Pyridoxal; in medicines containing more than 200 milligrams per recommended daily dose

1593

Pyridoxamine; in medicines containing more than 200 milligrams per recommended daily dose

1594

Pyridoxine; in medicines containing more than 200 milligrams per recommended daily dose

1595

Pyrimethamine

1596

Pyrvinium

1597

Quazepam

1598

Quetiapine

1599

Quinagolide

1600

Quinapril

1601

Quinbolone

1602

Quinethazone

1603

Quinidine

1604

Quinine; except in medicines containing 50 milligrams or less per recommended daily dose

1605

Quinisocaine

1606

Quinupristin

1607

Rabeprazole

1608

Rabies vaccine

1609

Raloxifene

1610

Raltegravir

1611

Raltitrexed

1612

Ramipril

1613

Ranibizumab

1614

Ranitidine; except when specified elsewhere in this schedule; except in medicines containing 150 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 7 days’ supply

1615

Rapacuronium

1616

Rasagiline

1617

Rasburicase

1618

Rauwolfia serpentina

1619

Rauwolfia vomitoria

1620

Razoxane

1621

Reboxetine

1622

Regorafenib

1623

Remestemcel-L

1624

Remifentanil

1625

Remoxipride

1626

Repaglinide

1627

Reserpine

1628

Retapamulin

1629

Reteplase

1630

Retigabine

1631

Ribavirin

1632

Ridaforolimus

1633

Rifabutin

1634

Rifampicin

1635

Rifamycin

1636

Rifapentine

1637

Rifaximin

1638

Rilpivirine

1639

Riluzole

1640

Rimexolone

1641

Rimiterol

1642

Rimonabant

1643

Riociguat

1644

Risedronic acid

1645

Risperidone

1646

Ritodrine

1647

Ritonavir

1648

Rituximab

1649

Rivaroxaban

1650

Rivastigmine

1651

Rizatriptan; except when specified elsewhere in this schedule

1652

Rocuronium

1653

Rofecoxib

1654

Roflumilast

1655

Rolitetracycline

1656

Romidepsin

1657

Romiplostim

1658

Ropinirole

1659

Ropivacaine

1660

Rosiglitazone

1661

Rosoxacin

1662

Rosuvastatin

1663

Rotavirus vaccine

1664

Rotigotine

1665

Roxibolone

1666

Roxithromycin

1667

Rubella vaccine

1668

Ruboxistaurin

1669

Rupatadine

1670

Ruxolitnib

1671

Sabadilla; except in preparations containing 10 milligrams or less of total alkaloids of schoenocaulon officinale per litre or per kilogram

1672

Safrole; for internal use except in medicines containing 0.1% or less

1673

Salbutamol

1674

Salcatonin

1675

Salmeterol

1676

Sapropterin

1677

Saquinavir

1678

Saxagliptin

1679

Schoenocaulon officinale; except in preparations containing 10 milligrams or less of total alkaloids of schoenocaulon officinale per litre or per kilogram

1680

Scopolia carniolica

1681

Secbutabarbital

1682

Secobarbital

1683

Selective androgen receptor modulators

1684

Selegiline

1685

Selenium; except when specified elsewhere in this schedule; except for oral use in medicines containing 150 micrograms or less per recommended daily dose; except for external use in medicines containing 3.5% or less of selenium sulphide

1686

Selexipag

1687

Serelaxin

1688

Sermorelin

1689

Sertindole

1690

Sertraline

1691

Serum, dried human

1692

Sevelamer

1693

Sevoflurane

1694

Sex hormones and all substances having sex hormone activity

1695

Sialoepoetin

1696

Sibutramine

1697

Silandrone

1698

Sildenafil and its structural analogues; except sildenafil in medicines for oral use containing 100 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 12 solid dosage units for the treatment of erectile dysfunction in males aged 35–70 years by a registered pharmacist who has successfully completed a training programme endorsed by the Pharmaceutical Society of New Zealand

1699

Silicones; for injection

1700

Siltuximab

1701

Silver sulfadiazine; except for external use in packs containing 50 grams or less

1702

Simeprevir

1703

Simvastatin

1704

Sirolimus

1705

Sisomicin

1706

Sitagliptin

1707

Sitaxentan

1708

Sodium bromide

1709

Sodium cellulose phosphate; for internal use

1710

Sodium cromoglycate; except for nasal and ophthalmic use

1711

Sodium morrhuate; for injection

1712

Sodium nitroprusside

1713

Sodium phosphate; in oral laxative preparations

1714

Sodium polystyrene sulphonate

1715

Sodium tetradecyl sulphate; for injection

1716

Sofosbuvir

1717

Solasadine

1718

Solifenacin

1719

Somatostatin

1720

Somatropin

1721

Sontoquine

1722

Sorafenib

1723

Sotalol

1724

Sparfloxacin

1725

Sparteine

1726

Spectinomycin

1727

Spiramycin

1728

Spirapril

1729

Spironolactone

1730

Stanolone

1731

Stanozolol

1732

Staphylococcus aureus vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

1733

Stavudine

1734

Stenbolone

1735

Steroid hormones

1736

Stilboestrol

1737

Stramonium; except for oral use when specified elsewhere in this schedule; except datura stramonium or datura tatula for smoking or burning

1738

Streptococcus beta-haemolyticus vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

1739

Streptodornase

1740

Streptokinase

1741

Streptomycin

1742

Strontium ranelate

1743

Strophanthins

1744

Strophanthus spp

1745

Strychnos spp; except in medicines containing 1 milligram or less per litre or per kilogram of strychnine

1746

Styramate

1747

Succimer

1748

Sufentanil

1749

Sugammadex

1750

Sulbactam

1751

Sulconazole; except for dermal use

1752

Sulfacetamide; except for ophthalmic use in medicines containing 10% or less

1753

Sulfadiazine; except silver sulfadiazine for external use in pack sizes of 50 grams or less

1754

Sulfadimethoxine

1755

Sulfadimidine

1756

Sulfadoxine

1757

Sulfafurazole

1758

Sulfaguanidine

1759

Sulfamerazine

1760

Sulfamethizole

1761

Sulfamethoxazole

1762

Sulfamethoxydiazine

1763

Sulfamethoxypyridazine

1764

Sulfametrole

1765

Sulfamonomethoxine

1766

Sulfamoxole

1767

Sulfaphenazole

1768

Sulfapyridine

1769

Sulfasalazine

1770

Sulfathiazole

1771

Sulfatroxazole

1772

Sulfinpyrazone

1773

Sulfomyxin

1774

Sulfonmethane

1775

Sulindac

1776

Sultamicillin

1777

Sulthiame

1778

Sumatriptan; except when specified elsewhere in this schedule

1779

Sunitinib

1780

Suprofen

1781

Sutilains

1782

Suxamethonium

1783

Suxethonium

1784

T cell receptor antibody

1785

Tacrine

1786

Tacrolimus

1787

Tadalafil and its structural analogues

1788

Tafluprost

1789

Taliglucerase alfa

1790

Tamoxifen

1791

Tamsulosin

1792

Tanacetum vulgare; in medicines containing more than 0.8% of oil of tansy

1793

Tapentadol

1794

Tasonermin

1795

Tazarotene

1796

Tazobactam

1797

Tegafur

1798

Tegaserod

1799

Teicoplanin

1800

Telaprevir

1801

Telbivudine

1802

Telithromycin

1803

Telmisartan

1804

Temazepam

1805

Temozolomide

1806

Temsirolimus

1807

Tenecteplase

1808

Teniposide

1809

Tenofovir

1810

Tenoxicam

1811

Terazosin

1812

Terbinafine; except in medicines for dermal use

1813

Terbutaline

1814

Terfenadine

1815

Teriflunomide

1816

Teriparatide

1817

Terlipressin

1818

Terodiline

1819

Teropterin

1820

Tesamorelin

1821

Testolactone

1822

Testosterone; except in medicines containing 1 milligram or less per litre or per kilogram

1823

Tetanus antitoxin

1824

Tetanus toxoid

1825

Tetanus vaccine

1826

Tetrabenazine

1827

Tetracosactrin

1828

Tetracycline

1829

Tetraethylammonium

1830

Tetrahydrocannabinol

1831

Tetrazepam

1832

Tetroxoprim

1833

Thalidomide

1834

Thenyldiamine

1835

Theophylline; except in liquid form for oral use in medicines containing 2% or less

1836

Thevetia peruviana

1837

Thevetin

1838

Thiambutosine

1839

Thiazosulfone

1840

Thiethylperazine

1841

Thioacetazone

1842

Thiocarlide

1843

Thioguanine

1844

Thiomesterone

1845

Thiopentone

1846

Thiopropazate

1847

Thioproperazine

1848

Thioridazine

1849

Thiotepa

1850

Thiothixene

1851

Thiouracil

1852

Thiourea; except in medicines containing 0.1% or less

1853

Thymoxamine

1854

Thyroid

1855

Thyrotrophin

1856

Thyrotrophin-releasing factor

1857

Thyroxine; except in medicines containing 10 micrograms or less per litre or per kilogram

1858

Tiagabine

1859

Tiaprofenic acid

1860

Tiaramide

1861

Tibolone

1862

Ticagrelor

1863

Ticarcillin

1864

Ticlopidine

1865

Tiemonium

1866

Tienilic acid

1867

Tigecycline

1868

Tigloidine

1869

Tiletamine

1870

Tilidine

1871

Tiludronic acid

1872

Timolol

1873

Tinidazole

1874

Tinzaparin

1875

Tioconazole; except in medicines for vaginal or dermal use

1876

Tiotropium

1877

Tipepidine

1878

Tiprinavir

1879

Tirilazad

1880

Tirofiban

1881

Tobramycin

1882

Tocainide

1883

Tocilizumab

1884

Tolazamide

1885

Tolazoline

1886

Tolbutamide

1887

Tolcapone

1888

Tolfenamic acid

1889

Tolmetin

1890

Tolonium

1891

Tolpropamine

1892

Tolrestat

1893

Tolterodine

1894

Tolvaptan

1895

Topiramate

1896

Topotecan

1897

Torasemide

1898

Toremifene

1899

Toxoids; for injection

1900

Tramadol

1901

Trametinib dimethyl sulfoxide

1902

Trandolapril

1903

Tranexamic acid

1904

Tranylcypromine

1905

Trastuzumab

1906

Trastuzumab emtansine

1907

Travoprost

1908

Trazodone

1909

Trenbolone

1910

Treosulphan

1911

Treprostinil

1912

Trestolone

1913

Tretamine

1914

Tretinoin

1915

Triacetyloleandomycin

1916

Triamcinolone; except when specified elsewhere in this schedule

1917

Triamterene

1918

Triaziquone

1919

Triazolam

1920

Trichlormethiazide

1921

Trichloroacetic acid; except for external use in medicines containing 12.5% or less for the treatment of warts other than anogenital warts

1922

Trichloroethylene

1923

Trichodesma africana; at all strengths

1924

Triclofos

1925

Tricyclamol

1926

Tridihexethyl

1927

Trifluoperazine

1928

Trifluperidol

1929

Triflupromazine

1930

Trimeprazine; except when specified elsewhere in this schedule

1931

Trimetaphan

1932

Trimethoprim; except in medicines for oral use containing 300 milligrams or less per dose unit when sold in a pack of 3 solid dosage units to a woman aged 16–65 years for the treatment of an uncomplicated urinary tract infection by a registered pharmacist who has successfully completed the New Zealand College of Pharmacists’ training in the treatment of urinary tract infections

1933

Trimipramine

1934

Trimustine

1935

Trinitrophenol

1936

Trioxysalen

1937

Triparanol; at all strengths

1938

Triple antigen vaccine

1939

Triprolidine; except when specified elsewhere in this schedule

1940

Triptorelin

1941

Troglitazone

1942

Trometamol; for injection in medicines containing more than 3%

1943

Tropicamide; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

1944

Tropisetron

1945

Trovafloxacin

1946

Troxidone

1947

Tryptophan; in medicines containing more than 100 milligrams per recommended daily dose except in parenteral nutrition replacement preparations

1948

Tuberculin

1949

Tuberculosis vaccine

1950

Tubocurarine

1951

Tulobuterol

1952

Typhoid vaccine

1953

Umeclidinium bromide

1954

Unoprostone

1955

Uracil

1956

Urapidil

1957

Urethane

1958

Urofollitropin

1959

Urokinase

1960

Ursodeoxycholic acid

1961

Ustekinumab

1962

Vaccines; except when specified elsewhere in this schedule

1963

Vaccinia virus vaccine

1964

Valaciclovir

1965

Valdecoxib

1966

Valganciclovir

1967

Valnoctamide

1968

Valproic acid

1969

Valsartan

1970

Vancomycin

1971

Vandetanib

1972

Vardenafil and its structural analogues

1973

Varenicline

1974

Varicella vaccine; except when administered for the prevention of herpes zoster (shingles) to a person 50 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

1975

Vasopressin

1976

Vecuronium

1977

Vedolizumab

1978

Velaglucerase alfa

1979

Vemurafenib

1980

Venlafaxine

1981

Verapamil

1982

Veratrum spp

1983

Vernakalant

1984

Verteporfin

1985

Veruprevir

1986

Vidarabine

1987

Vigabatrin

1988

Vilanterol

1989

Vildagliptin

1990

Viloxazine

1991

Vinblastine

1992

Vincamine

1993

Vincristine

1994

Vindesine

1995

Vinflunine

1996

Vinorelbine

1997

Vinyl ether

1998

Virginiamycin

1999

Vismodegib

2000

Visnadine

2001

Vitamin A; for internal use in medicines containing more than 3 milligrams of retinol equivalents per recommended daily dose except in parenteral nutrition replacement preparations; for external use in medicines containing more than 1%

2002

Vitamin D; for internal use in medicines containing more than 25 micrograms per recommended daily dose except in parenteral nutrition replacement preparations

2003

Voriconazole

2004

Vorinostat

2005

Vortioxetine

2006

Warfarin

2007

Xamoterol

2008

Xanthinol nicotinate

2009

Ximelagatran

2010

Xipamide

2011

Yellow fever vaccine

2012

Yohimbine

2013

Zafirlukast

2014

Zalcitabine

2015

Zaleplon

2016

Zanamivir

2017

Zidovudine

2018

Zimeldine

2019

Zinc; for internal use in medicines containing more than 25 milligrams per recommended daily dose; except for internal use in medicines containing 50 milligrams or less and more than 25 milligrams per recommended daily dose in packs that have received the consent of the Minister or the Director-General to their distribution as general sale medicines, when sold in the manufacturer’s original pack and when labelled with a statement that the product may be dangerous if taken in large amounts or for long periods; except in parenteral nutrition replacement preparations

2020

Ziprasidone

2021

Zoledronic acid

2022

Zolmitriptan; except when specified elsewhere in this schedule

2023

Zolpidem

2024

Zonisamide

2025

Zopiclone

2026

Zoster immunoglobulin, human

2027

Zoxazolamine

2028

Zuclopenthixol

Part 2 Restricted medicines

1

Adrenaline; in medicines containing 1% or less except in medicines for injection containing 0.02% or less

2

Alclometasone; for dermal use in medicines containing 0.05% or less and in packs containing not more than 30 grams that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack

3

Aminophylline; for oral use in liquid form in medicines containing 2% or less

4

Amorolfine; for external use in medicines containing more than 0.25%

5

Aspirin; in slow-release forms; in enteric coated forms containing more than 300 milligrams per dose form; except when specified elsewhere in this schedule

6

Azatadine; for oral use in adults and children over 2 years of age

7

Azelastine; in medicines for ophthalmic use containing 0.05% or less

8

Brompheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of anxiety or insomnia; for oral use for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

9

Buclizine; for oral use

10

Butoconazole; for vaginal use

11

Chloramphenicol; for ophthalmic use; except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

12

Chlorbutol; in medicines containing more than 5%

13

Chlorpheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of anxiety or insomnia; for oral use for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

14

Ciclopirox; for external use in medicines containing more than 2%; in preparations for application to the nails containing more than 8%

15

Cimetidine; in medicines for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner, when sold in the manufacturer’s original pack containing not more than 14 days’ supply

16

Clemastine; for oral use

17

Clobetasone; for dermal use in medicines containing 0.05% or less and in packs containing not more than 30 grams that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack

18

Clotrimazole; for vaginal use

19

Codeine; in medicines for oral use containing not more than 15 milligrams of codeine per solid dosage unit or per dose of liquid with a maximum daily dose not exceeding 100 milligrams of codeine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield that would constitute a risk to health, for use as an analgesic and when sold in a pack of not more than 5 days’ supply, approved by the Minister or the Director-General for distribution as a restricted medicine

20

Cyclizine; for oral use other than in medicines used for the treatment of anxiety or insomnia; for oral use for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

21

Cyproheptadine; for oral use

22

Dexchlorpheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of anxiety or insomnia; for oral use for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

23

Di-iodohydroxy quinoline; for vaginal use

24

Diclofenac; in solid dose form in medicines containing 25 milligrams or less and more than 12.5 milligrams per dose form in packs containing not more than 30 tablets or capsules

25

Dimenhydrinate; for oral use in medicines for adults and children over 2 years of age; except when specified elsewhere in this schedule

26

Dimethindene; for oral use

27

Diphenhydramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of anxiety or insomnia; for oral use for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

28

Dithranol

29

Doxylamine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of anxiety or insomnia; for oral use for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

30

Econazole; for vaginal use

31

Erythrityl tetranitrate

32

Famciclovir; in divided solid dosage forms for oral use containing 500 milligrams or less for the treatment of recurrent herpes labialis when sold in the manufacturer’s original pack containing up to 3 dosage units

33

Flavoxate

34

Fluconazole; for oral use in medicines that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack containing 150 milligrams or less as a single dose for the treatment of vaginal candidiasis

35

Fluorides; for external use in liquid form in medicines containing 5.5 grams or less and more than 1 gram per litre or per kilogram and when sold in packs approved by the Minister or the Director-General for distribution as restricted medicines; for external use in non-liquid form in medicines containing 5.5 grams or less and more than 1 gram per litre or per kilogram, except in medicines containing 1.5 grams or less and more than 1 gram per litre or per kilogram; except when supplied to a dental professional registered with the Dental Council

36

Glucagon; except in medicines containing 100 micrograms or less per litre or per kilogram

37

Glyceryl trinitrate; for oral or sublingual use; for rectal use

38

Guaiphenesin; for oral use in modified release form with a maximum recommended daily dose of not more than 2.4 grams when sold in the manufacturer’s original pack containing more than 10 days’ supply but not more than 30 days’ supply

39

Haemophilus influenzae vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

40

Hydrocortisone and hydrocortisone acetate but no other esters of hyrocortisone; for dermal use in medicines containing 1% or less but more than 0.5% by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of 30 grams or less or 30 millilitres or less per container; in rectal medicines containing 1% or less but more than 0.5% by weight of hydrocortisone base and in combination with a local anaesthetic and in a quantity of 35 grams or less per container or up to 12 suppositories per pack

41

Hyoscine butylbromide; for oral use in medicines containing not more than 20 milligrams per dose form and in packs containing not more than 10 tablets or capsules for the relief of muscle spasm of the gastrointestinal tract

42

Ibuprofen; for oral use in tablets or capsules containing up to 400 milligrams per dose form and in packs containing not more than 50 dose units and that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack labelled for use by adults or children over 12 years of age

43

Inositol nicotinate

44

Isoconazole; for vaginal use

45

Ketoprofen; in solid dose form containing 25 milligrams or less per dose form in packs of not more than 30 capsules or tablets

46

Lansoprazole; in divided solid dosage forms for oral use containing 15 milligrams or less with a maximum daily dose of 15 milligrams for the short-term symptomatic relief of gastric reflux-like symptoms in sufferers aged 18 years and over for the relief of heartburn when sold in the manufacturer’s original pack containing not more than 14 dosage units

47

Levonorgestrel; in medicines for use as emergency post-coital contraception when in packs containing not more than 1.5 milligrams except when sold by nurses recognised by their professional body as having competency in the field of sexual and reproductive health

48

Macrogols; in oral preparations for bowel cleansing prior to diagnostic, medical, or surgical procedures

49

Malathion; for external use in medicines containing more than 2%

50

Mannityl hexanitrate

51

Meclozine; in a pack size of up to 10 dosage units for the treatment of anxiety or insomnia

52

Mepyramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of anxiety or insomnia; for oral use for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

53

Methdilazine; for oral use

54

Metoclopramide; when compounded with paracetamol in packs of not more than 10 tablets or capsules for the treatment of nausea associated with migraine

55

Miconazole; for the treatment of oral candidiasis; for vaginal use

56

Nicotinic acid except nicotinamide; in medicines containing 250 milligrams or less but more than 100 milligrams per dose form

57

Nicotinyl alcohol; in medicines containing more than 100 milligrams per dose form

58

Nystatin; for the treatment of oral candidiasis; for vaginal use

59

Omeprazole; in tablets or capsules containing 20 milligrams or less when sold in a pack approved by the Minister or the Director-General for distribution as a restricted medicine

60

Orlistat; in medicines for weight control containing 120 milligrams or less per dose form

61

Oseltamivir; in solid dosage forms for oral use containing 75 milligrams in a pack size of up to 10 dosage units for the treatment or prophylaxis of influenza in adults and children aged 13 years and older who have been exposed to the influenza virus

62

Oxiconazole; for vaginal use

63

Pantoprazole; in tablets or capsules containing 20 milligrams or less of pantoprazole when sold in a pack approved by the Minister or the Director-General for distribution as a restricted medicine

64

Pheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of anxiety or insomnia; for oral use for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

65

Pneumococcal vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

66

Podophyllotoxin; for external use for the treatment of warts other than anogenital warts in medicines containing 1% or less and more than 0.5%; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

67

Podophyllum emodi; for external use for the treatment of warts other than anogenital warts in medicines containing 20% or less and more than 10% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

68

Podophyllum peltatum; for external use for the treatment of warts other than anogenital warts in medicines containing 20% or less and more than 10% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

69

Prochlorperazine; in packs containing not more than 10 tablets or capsules for the treatment of nausea associated with migraine

70

Promethazine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of anxiety or insomnia; for oral use for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

71

Rizatriptan; for oral use in medicines for the acute relief of migraine attacks with or without aura in patients who have a stable, well-established pattern of symptoms, when in wafers containing 5 milligrams or less per wafer and when sold in a pack containing not more than 2 wafers approved by the Minister or the Director-General for distribution as a restricted medicine

72

Salicylic acid; except in medicines for dermal use containing 40% or less

73

Santonin

74

Sodium phosphate; in oral preparations for bowel cleansing prior to diagnostic, medical, or surgical procedures

75

Sodium picosulphate; in oral preparations for bowel cleansing prior to diagnostic, medical, or surgical procedures

76

Staphyloccocus aureus vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

77

Stramonium; for oral use in liquid form; in solid dose form in medicines containing more than 0.3 milligrams per dose or more than 1.2 milligrams per recommended daily dose

78

Streptococcus beta-haemolyticus vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

79

Sulfacetamide; for ophthalmic use in medicines containing 10% or less

80

Sumatriptan; for oral use in medicines for the acute relief of migraine attacks with or without aura in patients who have a stable, well-established pattern of symptoms when in tablets containing 50 milligrams or less per tablet and when sold in a pack containing not more than 2 tablets that has received the consent of the Minister or the Director-General to its sale as a restricted medicine

81

Theophylline; in liquid form for oral use in medicines containing 2% or less

82

Tioconazole; for vaginal use

83

Triamcinolone; for buccal use in medicines containing 0.1% or less of triamcinolone acetonide and in pack sizes of 5 grams or less

84

Trimeprazine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of anxiety or insomnia; for oral use for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

85

Triprolidine; for oral use in medicines for adults and children over 2 years of age; except when specified elsewhere in this schedule

86

Zolmitriptan; in a pre-filled nasal spray device containing not more than 5 milligrams of zolmitriptan, for the acute relief of migraine attacks with or without aura in patients who have a stable, well-established pattern of symptoms and when sold in a pack of not more than 2 devices approved by the Minister or the Director-General for distribution as a restricted medicine

Part 3 Pharmacy-only medicines

1

8-hydroxyquinoline and its non-halogenated derivatives; in medicines containing more than 1% of such substances

2

Acetic acid and preparations containing more than 80% of acetic acid (CH3COOH); excluding its salts and derivatives

3

Acetylcysteine; for oral use in medicines containing more than 1 gram per recommended daily dose

4

Aciclovir; for external use for the treatment of herpes labialis except in medicines containing 5% or less and in tubes containing 10 grams or less

5

Aconitum spp; for oral use in packs containing 0.2 milligrams or less and more than 0.02 milligrams of total alkaloids; for dermal use in concentrations of 0.02% or less and in packs containing 0.2 milligrams or less and more than 0.02 milligrams of total alkaloids

6

Aloes; for internal use; except when obtained solely from the mucilaginous gel of the leaf

7

Aloin

8

Aloxiprin

9

Amethocaine; for external use in medicines containing 10% or less and more than 2%

10

Amorolfine; in preparations for topical use except in preparations for the treatment of tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

11

Antazoline; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

12

Atropa belladonna; for external use in medicines containing 0.03% or less of the alkaloids of belladonna; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of the alkaloids of belladonna or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of the alkaloids of belladonna

13

Atropine; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose; in medicines containing atropine sulphate for the treatment of organophosphorus poisoning either in packs of not more than 20 dose units containing 0.6 milligrams or less per dose unit or in injections in packs of not more than 5 vials containing 0.6 milligrams per millilitre; except when sold as an antidote in a device designed for self-injection from outlets licensed to sell organophosphorus poisons; except in medicines containing 300 micrograms or less per litre or per kilogram

14

Azelaic acid; for dermal use

15

Azelastine; for nasal use; in topical eye preparations containing 0.05% or less

16

Beclomethasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age in aqueous nasal sprays delivering up to 50 micrograms per actuation when the maximum recommended daily dose is no greater than 400 micrograms (200 micrograms per nostril) in a pack containing 200 actuations or less

17

Benzocaine; in preparations for topical use, other than eye drops, containing 10% or less of total anaesthetic substances except in dermal preparations containing 2% or less of total anaesthetic substances; in divided preparations containing 200 milligrams or less of total anaesthetic substances per dosage unit except in lozenges containing 30 milligrams or less of total anaesthetic substances per dosage unit

18

Benzoyl peroxide; for external use in medicines containing more than 5% and not more than 10%

19

Benzydamine; for external use except for dermal use

20

Bephenium

21

Bifonazole; for dermal use except in medicines for tinea pedis only or in shampoos containing 1% or less

22

Bisacodyl

23

Bromhexine

24

Brompheniramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing brompheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

25

Budesonide; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age in aqueous nasal sprays delivering up to 50 micrograms per actuation and when the maximum recommended daily dose is no greater than 400 micrograms (200 micrograms per nostril) in a pack containing 200 actuations or less

26

Carbetapentane; in medicines containing more than 0.5%

27

Carbocisteine

28

Cetirizine; for oral use except in divided solid dosage forms for oral use containing 10 milligrams or less of cetirizine hydrochloride per dose form for the treatment of seasonal allergic rhinitis when sold in the manufacturer’s original pack containing not more than 5 days’ supply

29

Chlophedianol

30

Chlorbutol; in medicines containing 5% or less and more than 0.5%

31

Chloroform; in medicines other than for anaesthesia containing more than 0.5%

32

Chlorpheniramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing chlorpheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

33

Ciclopirox; for external use in medicines containing 2% or less except when for the treatment of tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board; in preparations for application to the nails containing 8% or less

34

Cinchocaine; for external use in medicines containing 0.5% or less

35

Cinnamedrine

36

Clotrimazole; for external use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

37

Cocaine; in medicines for oral use, containing not more than 0.1% of cocaine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield that would constitute a risk to health, and when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine

38

Codeine; in medicines for oral use, containing not more than 15 milligrams of codeine per solid dosage unit or per dose of liquid with a maximum daily dose not exceeding 100 milligrams of codeine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield that would constitute a risk to health, for the treatment of the symptoms of cough and cold and when sold in a pack of not more than 6 days’ supply, approved by the Minister or the Director-General for distribution as a pharmacy-only medicine

39

Colocynth

40

Creosote; in medicines containing more than 10%

41

Cresols; in medicines containing more than 3%

42

Datura spp; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

43

Delphinium staphisagria; in medicines containing more than 0.2%

44

Desloratadine; for oral use

45

Dexchlorpheniramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing dexchlorpheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

46

Dextromethorphan; in liquid form containing more than 0.25% or in solid dose form containing more than 15 milligrams per dose form when in packs containing not more than 600 milligrams and with a recommended daily dose of not more than 120 milligrams; in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years

47

Dibrompropamidine; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

48

Diclofenac; in solid dose form in medicines containing 12.5 milligrams or less per dose form in packs containing not more than 30 tablets or capsules and with a recommended daily dose of not more than 75 milligrams

49

Diphenoxylate; in liquid form containing in each millilitre not more than 0.5 milligrams of diphenoxylate calculated as base and not less than 5 micrograms of atropine sulphate; in solid dose form containing not more than 2.5 milligrams of diphenoxylate calculated as base and not less than 5 micrograms of atropine sulphate

50

Dimenhydrinate; for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults or children over 2 years of age except when sold at a transport terminal or aboard a ship or aircraft

51

Diphenhydramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing diphenhydramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant; for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults and children over 2 years of age except when sold at a transport terminal or aboard a ship or aircraft

52

Doxylamine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing doxylamine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

53

Duboisia leichhardtii; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

54

Duboisia myoporides; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

55

Econazole; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

56

Etafedrine

57

Ether; in medicines containing more than 10%

58

Etofenamate; for external use

59

Famotidine; for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner, when sold in the manufacturer’s original pack containing not more than 14 days’ supply

60

Felbinac; for external use

61

Fexofenadine; for oral use except for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when in capsules containing 60 milligrams or less of fexofenadine hydrochloride or in tablets containing 120 milligrams or less of fexofenadine hydrochloride with a maximum daily dose of 120 milligrams when sold in the manufacturer’s original pack containing 10 dosage units or less and not more than 5 days’ supply

62

Fluorides; for internal use in medicines containing 0.5 milligrams or less per dose unit; except in parenteral nutrition replacement preparations; for external use in liquid form in medicines containing 1 gram or less per litre or per kilogram and when sold in packs approved by the Minister or the Director-General for distribution as pharmacy-only medicines except in medicines containing 220 milligrams or less per litre or per kilogram and in packs containing not more than 120 milligrams of total fluoride; except when supplied to any dental professional registered with the Dental Council; except in medicines containing 15 milligrams or less per litre or per kilogram

63

Flurbiprofen; in locally acting oromucosal preparations containing 10 milligrams or less per dosage unit

64

Fluticasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age when in aqueous nasal sprays delivering up to 50 micrograms per actuation with a maximum recommended daily dose of 200 micrograms (as a single dose) in a pack containing 200 actuations or less

65

Folic acid; for oral use in medicines containing more than 500 micrograms per recommended daily dose

66

Folinic acid; for oral use in medicines containing more than 500 micrograms per recommended daily dose

67

Formaldehyde; in medicines containing more than 5%

68

Gelsemium sempervirens; except in medicines containing 1 milligram or less per litre or per kilogram

69

Glutaraldehyde

70

Hexachlorophane; in medicines containing 3% or less but more than 0.75%

71

Hydrocortisone and hydrocortisone acetate but no other esters of hydrocortisone; for dermal use in medicines containing 0.5% or less by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of 30 grams or less or 30 millilitres or less per container; in rectal medicines containing 0.5% or less by weight of hydrocortisone base and in combination with a local anaesthetic and in a quantity of 35 grams or less per container or 12 suppositories or fewer per pack

72

Hydrocyanic acid; for oral use in packs containing 5 milligrams or less and more than 0.5 milligrams; except in medicines containing 1 microgram or less per litre or per kilogram

73

Hydroquinone; for external use in medicines containing 2% or less except in hair preparations containing 1% or less

74

Hyoscine; for transdermal use in medicines containing 2 milligrams or less of total solanaceous alkaloids per dose unit; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

75

Hyoscyamine; for external use in medicines containing 0.03% or less of total solanaceous alkaloids; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

76

Hyoscyamus niger; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose except in packs containing 30 micrograms or less of total solanaceous alkaloids

77

Ibuprofen; for oral use in liquid form with a recommended daily dose of not more than 1.2 grams for the relief of pain and reduction of fever or inflammation when sold in the manufacturer’s original pack containing not more than 8 grams; for oral use in solid dose form containing not more than 200 milligrams per dose form and with a recommended daily dose of not more than 1.2 grams when sold in the manufacturer’s original pack containing not more than 100 dose units; except in divided solid dosage forms for oral use containing 200 milligrams or less per dose form with a recommended daily dose of not more than 1.2 grams and when sold in the manufacturer’s original pack containing not more than 25 dose units

78

Indanazoline

79

Indomethacin; for external use in medicines containing 1% or less; except in medicines containing 1 milligram or less per litre or per kilogram

80

Iodine; for external use in medicines containing more than 2.5%; for internal use in medicines containing 300 micrograms or more per recommended daily dose

81

Ipecacuanha; in medicines containing 0.2% or less of emetine and 40 micrograms or more of ipecacuanha alkaloids per recommended dose for the treatment of the symptoms of cough and cold in children aged 6–12 years

82

Ipomoea spp; except ipomoea batatas

83

Ipratropium; for nasal use

84

Iron; for oral use either in medicines containing more than 24 milligrams per recommended daily dose or in medicines containing more than 5 milligrams per dose unit and more than 750 milligrams of iron per pack; except in parenteral nutrition replacement preparations

85

Isoconazole; for dermal use except when sold in practice by a podiatrist registered with the Podiatrists Board

86

Isopropamide; for dermal use in preparations containing 2% or less

87

Jalap resin

88

Ketoconazole; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board; except in medicines for treatment of the scalp containing 1% or less

89

Ketotifen; for ophthalmic use in medicines containing 0.025% or less except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

90

Leucovorin; in medicines containing more than 500 micrograms per recommended daily dose

91

Levocabastine; for nasal use; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

92

Levocetirizine; for oral use

93

Lignocaine; for urethral use; for external use in medicines containing 10% or less and more than 2%

94

Lindane; for external use in medicines containing 2% or less

95

Lithium; for dermal use in medicines containing 1% or less but more than 0.01%; except when present as an excipient in dermal medicines containing 0.25% or less

96

Lobelia inflata; except in medicines for smoking or burning

97

Lobeline; except when in medicines for smoking or burning

98

Lodoxamide; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

99

Loperamide; in packs containing not more than 20 tablets or capsules; except in divided solid dosage forms for oral use containing 2 milligrams or less of loperamide per dosage form when sold in a pack containing not more than 8 dosage forms approved by the Minister or the Director-General for distribution as a general sales medicine for the symptomatic treatment of acute non-specific diarrhoea

100

Loratadine; for oral use except in divided solid dosage forms for oral use containing 10 milligrams or less per dose form for the treatment of seasonal allergic rhinitis when sold in the manufacturer’s original pack containing not more than 5 days’ supply

101

Mebendazole

102

Meclozine; in a sealed container of not more than 12 tablets or capsules for the prevention or treatment of travel sickness except when sold at a transport terminal or aboard a ship or aircraft

103

Mefenamic acid; in solid dose form in packs containing not more than 30 tablets or capsules for the treatment of dysmenorrhoea

104

Mepyramine; for dermal use

105

Mercuric oxide; for ophthalmic use

106

Mercurochrome; in preparations for external use containing 2% or less

107

Mercury; for external use in medicines containing 0.5% or less

108

Methoxamine; for external use in medicines containing more than 1%

109

Methoxyphenamine

110

Methylephedrine

111

Miconazole; for external use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

112

Minoxidil; for dermal use in medicines containing 5% or less

113

Mometasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age in aqueous nasal sprays delivering up to 50 micrograms per actuation when the maximum recommended daily dose is no greater than 200 micrograms (as a single dose) in a pack containing 200 actuations or less

114

Morphine; in medicines for oral use containing not more than 0.2% of morphine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield that would constitute a risk to health, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine

115

Naphazoline; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

116

Naproxen; in solid dose form containing 250 milligrams or less per dose form in packs of not more than 30 tablets or capsules

117

Niclosamide

118

Nicotine; for inhalation except when sold from a smoking cessation clinic run under the auspices of a registered medical practitioner, nurse, pharmacist, or psychologist

119

Nizatidine; in medicines for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner, when sold in the manufacturer’s original pack containing not more than 14 days’ supply

120

Noscapine

121

Nystatin; for dermal use except when sold in practice by a podiatrist registered with the Podiatrists Board

122

Omeprazole; in divided solid dosage forms for oral use containing 20 milligrams or less with a maximum daily dose of 20 milligrams for the short-term symptomatic relief of gastric reflux-like symptoms in sufferers aged 18 years and over when sold in the manufacturer’s original pack containing not more than 28 dosage units

123

Opium; in medicines for oral use containing not more than 0.2% of morphine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means, or in a yield that would constitute a risk to health, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine

124

Oxetacaine; for internal use

125

Oxiconazole; for dermal use except in medicines for tinea pedis only

126

Oxymetazoline; except for nasal use when sold at an airport; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; except for nasal use in medicines containing 0.05% or less when sold in the manufacturer’s original pack with a pack size of 20 millilitres or less

127

Pantoprazole; in divided solid dosage forms for oral use containing 20 milligrams or less with a maximum daily dose of 20 milligrams for the short-term symptomatic relief of gastric reflux-like symptoms in sufferers aged 18 years and over when sold in the manufacturer’s original pack containing not more than 28 dosage units

128

Papaverine; except for injection

129

Paracetamol; in liquid form; in suppositories; in tablets or capsules containing 500 milligrams or less and in packs containing more than 10 grams; in slow-release forms containing 665 milligrams or less and more than 500 milligrams; in powder form containing not more than 1 gram per sachet and more than 10 grams per pack

130

Paraformaldehyde; in medicines containing more than 5%

131

Penciclovir; for external use for the treatment of herpes labialis

132

Phedrazine

133

Phenazone; for external use

134

Pheniramine; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing pheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

135

Phenol; in medicines other than for injection containing more than 3%

136

Phenylephrine; for nasal use in medicines containing more than 1%; for ophthalmic use in medicines containing 5% or less and more than 1%; for oral use in medicines containing more than 50 milligrams per recommended daily dose or in packs containing more than 250 milligrams of phenylephrine per pack; in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years

137

Pholcodine; in medicines for oral use containing not more than 15 milligrams of pholcodine per solid dosage unit or per dose of liquid with a maximum daily dose not exceeding 100 milligrams of pholcodine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means, or in a yield that would constitute a risk to health, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine

138

Piperazine

139

Podophyllotoxin; for external use for the treatment of warts other than anogenital warts in medicines containing 0.5% or less; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

140

Podophyllum emodi; for external use for the treatment of warts other than anogenital warts in medicines containing 10% or less of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

141

Podophyllum peltatum; for external use for the treatment of warts other than anogenital warts in medicines containing 10% or less of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

142

Potassium; for internal use: in slow-release or enteric coated forms; in medicines containing more than 100 milligrams per recommended dose except in medicines for oral rehydration therapy, parenteral nutrition replacement, or dialysis; except in glucosamine sulphate complexed products containing 600 milligrams or less of potassium chloride per recommended dose

143

Potassium chlorate; except in medicines containing 10% or less

144

Prilocaine; for dermal use in medicines containing 10% or less of local anaesthetic substances

145

Procyclidine; for dermal use in medicines containing 5% or less

146

Promethazine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing promethazine or when at least 1 of the other active ingredients is a sympathomimetic decongestant; for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults and children over 2 years of age except when sold at a transport terminal or aboard a ship or aircraft

147

Propamidine; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

148

Pyrantel

149

Pyrethrins; in medicines containing more than 10%

150

Pyrithione zinc; except in medicines for treatment of the scalp containing 2% or less

151

Ranitidine; in medicines for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner, when sold in the manufacturer’s original pack containing not more than 14 days’ supply; except in medicines containing 150 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 7 days’ supply

152

Salicylamide

153

Selenium; for oral use in medicines containing 300 micrograms or less and more than 150 micrograms per recommended daily dose; for external use except in medicines containing 3.5% or less of selenium sulphide

154

Sennosides

155

Silver; except in oral solutions containing 0.3% or less or other medicines containing 1% or less

156

Silver sulfadiazine; for external use in pack sizes of 50 grams or less

157

Sodium cromoglycate; for nasal use; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

158

Sodium nitrite; except for use as an excipient

159

Sodium picosulphate; in oral laxative preparations

160

Squill; in medicines containing more than 1%

161

Stramonium; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

162

Sulconazole; for dermal use

163

Sulfadiazine, silver; for external use in pack sizes of 50 grams or less

164

Terbinafine; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

165

Tetrachloroethylene

166

Tetrahydrozoline; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

167

Thiabendazole

168

Tioconazole; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

169

Tramazoline

170

Triamcinolone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age and when in aqueous nasal sprays delivering up to 55 micrograms per actuation when the maximum recommended daily dose is no greater than 220 micrograms and the medicine has received the consent of the Minister or the Director-General to its distribution as a pharmacy-only medicine

171

Trimeprazine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing trimeprazine or when at least 1 of the other therapeutically active ingredients is a sympathomimetic decongestant

172

Triprolidine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing triprolidine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

173

Tuaminoheptane

174

Tymazoline

175

Xylenols; in medicines containing more than 3%

176

Xylometazoline; except for nasal use when sold at an airport; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

177

Zinc chloride; for dermal use in medicines containing more than 5%

 Michael Webster,
Clerk of the Executive Council.

Explanatory note

This note is not part of the regulations, but is intended to indicate their general effect.

These regulations, which come into force on 6 August 2015, replace Schedule 1 of the Medicines Regulations 1984 (the principal regulations). New Schedule 1 sets out an updated list of specified medicines and classes of medicines that are declared to be prescription medicines, restricted medicines, or pharmacy-only medicines under the Medicines Act 1981 (the Act).

The updated list includes medicines that the Minister of Health has previously classified as prescription medicines, etc, by Gazette notice made under section 106 of the Act (see Classification of Medicines (Gazette 2015-go984) and Classification of Medicines (Gazette 2014-go7770)). Gazette notices made under section 106 override any inconsistent classification of medicines in the principal regulations, but they do not amend the principal regulations and they cease to have effect after a period of 6 months (if not revoked sooner).

Issued under the authority of the Legislation Act 2012.

Date of notification in Gazette: 30 July 2015.

Reprints notes
1 General

This is a reprint of the Medicines Amendment Regulations (No 2) 2015 that incorporates all the amendments to those regulations as at the date of the last amendment to them.

2 Legal status

Reprints are presumed to correctly state, as at the date of the reprint, the law enacted by the principal enactment and by any amendments to that enactment. Section 18 of the Legislation Act 2012 provides that this reprint, published in electronic form, has the status of an official version under section 17 of that Act. A printed version of the reprint produced directly from this official electronic version also has official status.

3 Editorial and format changes

Editorial and format changes to reprints are made using the powers under sections 24 to 26 of the Legislation Act 2012. See also http://www.pco.parliament.govt.nz/editorial-conventions/.

4 Amendments incorporated in this reprint

Medicines Amendment Regulations 2018 (LI 2018/179): regulation 5